The Hong Kong exchange will soon launch futures contracts tied to the Hang Seng Biotech Index, offering investors a way to manage risk in one of Hong Kong’s fastest growing sectors.

Hong Kong Exchanges and Clearing (HKEX) is going to launch the Hang Seng Biotech Index Futures on 28 November.  The underlying index tracks the performance of the 30 largest biotech, pharmaceutical, and medical device companies listed in Hong Kong SAR.  The contracts will provide investors with targeted risk management options while complementing HKEX’s growing portfolio of biotech and equity index derivatives. 'Driven by innovation and strong global healthcare demand, th